August 12, 2022

Volume XII, Number 224

Advertisement
Advertisement

August 11, 2022

Subscribe to Latest Legal News and Analysis

August 10, 2022

Subscribe to Latest Legal News and Analysis

August 09, 2022

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
4
Aug
Argument Forfeit in Remand Notwithstanding Modified Claim Construction McDermott Will & Emery
4
Aug
Seeing Starz: No Damages Bar in Copyright Discovery Rule Case McDermott Will & Emery
4
Aug
Holdover Trademark Licensee Status Can’t Do Heavy Lifting on “Exceptionality” McDermott Will & Emery
4
Aug
Claim Construction Error Fuels Remand McDermott Will & Emery
4
Aug
Fee Award Appropriate for Trying to Refresh and Replay Case McDermott Will & Emery
3
Aug
China: Alternative Strategies to Trademark Enforcement against Parallel Import of Cosmetics by Unauthorized Sellers Squire Patton Boggs (US) LLP
3
Aug
AbbVie's Humira Patent Settlement Not a Violation of Sherman Antitrust Act, Seventh Circuit Affirms MoginRubin
3
Aug
NY Attorney Suspended for Filing Over 18,000 U.S. Trademark Applications for Chinese Agents Without Proper Review Schwegman, Lundberg & Woessner, P.A.
2
Aug
China: Metaverse and Chinese Trademark Filings Squire Patton Boggs (US) LLP
2
Aug
NFTs: For Many Retailers, the “N” Stands for Nostalgia Hunton Andrews Kurth
2
Aug
Healthcare Noncompete Laws Get a Checkup in Four States and the District of Columbia Epstein Becker & Green, P.C.
2
Aug
Case Update: Dwyer v Fredbar in the Court of Appeal Squire Patton Boggs (US) LLP
1
Aug
Lost Profits – Who’s Sale is it Anyway? Mintz
29
Jul
Finally a Way to Sanction Those Who Defraud the USPTO Norris McLaughlin P.A.
29
Jul
Trade Secret Law Evolution Podcast Episode 48: The Tenth Circuit Addresses Causation, Exemplary Damages, and Attorneys’ Fees under the Uniform Trade Secrets Act [PODCAST] Greenberg Traurig, LLP
28
Jul
Enforcement Challenges for Entertainment Trademark Owners OLIVARES
28
Jul
Past and Future: How Prior IPR Representations Can Haunt Your Future Patent Infringement Complaint Foley & Lardner LLP
28
Jul
Purposeful Direction in a Forum Activates the Long Arm of the Law Mintz
28
Jul
New WDTX Order Shakes Up Initial Judge Assignments McDermott Will & Emery
28
Jul
Federal Reserve Issues Stark Warning for Competitor Banks Looking to Poach Employees Jones Walker LLP

Pages